Comera Life Sciences Holdings, Inc.

OTCPK:CMRA Stock Report

Market Cap: US$6.1k

Comera Life Sciences Holdings Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Michael Campbell

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.7yrs
CEO ownership0.1%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates

Comera Life Sciences rises on positive preclinical data from Sequrus study

Oct 18

Comera life sciences expands woburn operations

Oct 04

Comera Life Sciences announces up to $15M purchase agreement with Arena

Aug 31

Comera Life Sciences GAAP EPS of -$1.14, revenue of $0.15M

Aug 10

Comera Life Sciences Holdings (NASDAQ:CMRA) Is In A Good Position To Deliver On Growth Plans

May 27
Comera Life Sciences Holdings (NASDAQ:CMRA) Is In A Good Position To Deliver On Growth Plans

CEO Compensation Analysis

How has Michael Campbell's remuneration changed compared to Comera Life Sciences Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2023n/an/a

-US$9m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$1mUS$202k

-US$18m

Compensation vs Market: Insufficient data to establish whether Michael's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Michael's compensation with company performance.

CEO

Michael Campbell (55 yo)

2.7yrs

Tenure

US$1,224,009

Compensation

Mr. Michael G. Campbell, CPA, serves as Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer of Comera Life Sciences Holdings, Inc. since January 31, 2024 and has been its Chie...

Board Members

NamePositionTenureCompensationOwnership
David Soane
Co-Founder & Member of Scientific Advisory Boardno datano data12.08%
$ 742.3
James Sherblom
Independent Director3.9yrsUS$81.25k1.47%
$ 90.4
John Sorvillo
Chairman of Scientific Advisory Boardno dataUS$520.24kno data
V. Lawlis
Member of Scientific Advisory Boardno datano datano data
Barbara Finck
Scientific Advisory Board1.9yrsUS$48.33kno data
John Carpenter
Member of Scientific Advisory Boardno datano datano data
Alan Herman
Member of Scientific Advisory Boardno datano datano data
John Yee
Scientific Advisory Board1.9yrsUS$48.33kno data
Andrew Jones
Member of Scientific Advisory Boardno datano datano data
Kirsten Flowers
Independent Director3.3yrsUS$58.54k0.072%
$ 4.4
Sirshendu Banerjee
Independent Director3.3yrsUS$62.92k0.094%
$ 5.8
Edward Sullivan
Independent Director3.3yrsUS$62.92k0.064%
$ 3.9

3.3yrs

Average Tenure

68yo

Average Age

Experienced Board: CMRA's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 01:05
End of Day Share Price 2024/12/27 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Comera Life Sciences Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution